You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • High-dose vitamin B supplements did not slow cognitive decline in patients with mild-to-moderate Alzheimer diseaseCommentary

Article Text

Article menu
Download PDFPDF
Treatment
High-dose vitamin B supplements did not slow cognitive decline in patients with mild-to-moderate Alzheimer disease

https://doi.org/10.1136/ebn.12.2.57

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    P S Aisen

    Dr P S Aisen, University of California, San Diego, CA, USA; paisen@ucsd.edu

    QUESTION

    Do high-dose vitamin B supplements reduce rate of cognitive decline in patients with Alzheimer disease (AD)?

    METHODS

    Design:

    randomised placebo controlled trial. Clinicaltrials.gov NCT00056225.

    Allocation:

    {concealed}.*

    Blinding:

    blinded (patients, caregivers, clinicians, and psychometrists).

    Follow-up period:

    every 3 months up to 18 months.

    Setting:

    40 centres in the USA.

    Patients:

    409 patients >50 years of age (mean age 76 y, 56% women), who had probable AD, scored 14–26 on the Mini-Mental State Examination (MMSE), and were medically stable. Exclusion criteria were vitamin B12 concentrations <129 pmol/l (175 pg/ml), folate concentrations <9.5 nmol/l (4.2 ng/ml), renal insufficiency (serum creatinine ⩾176.8 µmol/l [2.0 …

    View Full Text

    Footnotes

    • Source of funding: National Institute on Aging and National Institutes of Health.